Kintara Therapeutics Inc (NASDAQ:KTRA)

0.6416
BATS BZX Real-Time Price
As of 1:44pm ET
 +0.0416 / +6.93%
Today’s Change
0.50
Today|||52-Week Range
3.35
-49.88%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization0.0010.3K16.7K24.5K
 
 
 
 
 
Operating ExpensesGross Income0.00-10.3K-16.7K-24.5K
 
 
 
 
General Expenses4.7M6.2M8.3M11.2M
 
 
 
 
 
Research And Development2.6M3.4M5.0M7.1M
 
 
 
 
 
Total Operating Expenses4.7M6.2M8.3M11.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.7M-6.2M-8.3M-11.2M
 
 
 
 
 
Extraordinary Credit651.1K0.00246.0K60.1K
 
 
 
 
Extraordinary Charge-249.1K-2.6M0.000.00
 
 
 
Interest Expense On Debt2.1K0.000.000.00
 
 
Other Expenses-23.4K-13.8K-7.4K-57.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.3M-8.9M-8.1M-11.1M
 
 
 
 
 
Preferred Dividend-----790.5K-176.2K
 
 
 
Net Income-4.3M-8.9M-8.1M-11.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS951.7K1.1M1.2M2.1M
 
 
 
 
 
Shares To Calculate EPS Diluted951.7K1.1M1.2M2.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$4.40-$8.10-$7.40-$5.40
 
 
 
 
 
EPS Diluted-$4.40-$8.10-$7.40-$5.40